Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer

Prostate cancer (PCa) is a common cancer among males and a leading cause of cancer deaths. Docetaxel (DOC) was recommended in guidelines as the first first-line drug of PCa; however, treatment with high doses of DOC ultimately results in resistance. This study examined the proliferation, viability,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Sen, Zhang, Kun, He, Yan, Xu, Xuetao, Li, Dongli, Cheng, Shupeng, Zheng, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077455/
https://www.ncbi.nlm.nih.gov/pubmed/35541462
http://dx.doi.org/10.1039/c7ra11647k

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077455/
https://www.ncbi.nlm.nih.gov/pubmed/35541462
http://dx.doi.org/10.1039/c7ra11647k

Ejemplares similares